Anakinra treatment in patients with gout and type 2 diabetes (Q58326099)

1

0 references

Luca Cantarini

2

0 references

Donato Rigante

3

0 references

Marco Bardelli

The inflammasome--a linebacker of innate defense.

4

0 references

publication date

15 April 2014

0 references

published in

Clinical Rheumatology

0 references

volume

34

0 references

page(s)

981-984

0 references

issue

5

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Gout-associated uric acid crystals activate the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Neutralizing interleukin-1beta (IL-1beta) induces beta-cell survival by maintaining PDX1 protein nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Blocking interleukin-1β in acute and chronic autoinflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Treating inflammation by blocking interleukin-1 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

A pilot study of IL-1 inhibition by anakinra in acute gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

The effect of the interleukin-1 cytokine family members IL-1F6 and IL-1F8 on adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Interleukin-1 antagonists for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-014-2601-7

Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study

21 January 2018

1 reference

12 December 2020

Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis

1 reference

12 December 2020

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

1 reference

12 December 2020

Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout

1 reference

12 December 2020

Revisiting comorbidities in gout: a cluster analysis

1 reference

12 December 2020